TrialThe Lancet. Oncology2019

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

Graham H Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.